Endoscopic submucosal dissection for gastric adenocarcinoma of the fundic gland type (chief cell predominate type): Four years’ experience from a tertiary hospital
Journal of Digestive Diseases · 2022
DOI: 10.1111/1751-2980.13149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2022. Verfasst von Meng Jiang He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Stomach Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Shanghai "Rising Stars of Medical Talent" Youth Development Program.
Abstract (Originalsprache)
Objective
To summarize the endoscopic and clinicopathological features of gastric adenocarcinoma of the fundic gland type (GA‐FG), and to evaluate the efficacy and safety of endoscopic submucosal dissection (ESD) for the treatment of GA‐FGs.
Methods
From September 2017 to August 2021, patients treated with ESD who were pathologically confirmed to have GA‐FGs were included. Those with lymphovascular and distal metastasis were excluded before ESD. The medical records were retrospectively reviewed to obtain information regarding patient demographics, clinicopathological characteristics, tumor features, complete resection rate, and complications, etc. All patients underwent follow‐up for at least 12 months to evaluate any local recurrence or distant metastasis.
Results
A total of 15 patients with an average age of 56.9 ± 10.7 years were recruited, including 11 men and 4 women. Lesions were found at the upper third (13 [86.7%]) or middle third (2 [13.3%]) of the stomach. The average lesion size was 9.1 ± 4.8 mm. Macroscopically, lesions presented as a flat elevated type with reddish or erosion on top (n = 7, 46.7%), depressed type with pale color (n = 5, 33.3%), or submucosal tumor (SMT)‐like appearance type (n = 3, 20.0%). En bloc resection, complete resection and curative resection were achieved in 14 (93.3%), 13 (86.7%), and 11 (73.3%) patients, respectively. Nine (60.0%) of the lesions had submucosal invasion. One patient underwent additional surgery. No local recurrence or metastasis was detected during the follow‐up duration.
Conclusions
GA‐FGs present with various endoscopic features. ESD appears to be effective and safe for treating early‐stage GA‐FGs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
- Shanghai Collaborative Innovation Center of Endoscopy, Shanghai, China.
- Endoscopy Center, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, Fujian Province, China.
ORCID-Profile: Ping Hong Zhou
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Shanghai "Rising Stars of Medical Talent" Youth Development Program
- Shanghai Rising-Star Program
Zitieren
APA
He, M. J., Liu, X. Y., Xu, J. X., Xu, X. Y., Li, Q. L., Chen, W. F., & Zhou, P. H. (2022). Endoscopic submucosal dissection for gastric adenocarcinoma of the fundic gland type (chief cell predominate type): Four years’ experience from a tertiary hospital. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13149
Vancouver
He MJ, Liu XY, Xu JX, Xu XY, Li QL, Chen WF, et al. Endoscopic submucosal dissection for gastric adenocarcinoma of the fundic gland type (chief cell predominate type): Four years’ experience from a tertiary hospital. Journal of Digestive Diseases. 2022. doi:10.1111/1751-2980.13149
BibTeX
@article{He2022,
author = {He, Meng Jiang and Liu, Xin Yang and Xu, Jia Xin and Xu, Xiao Yue and Li, Quan Lin and Chen, Wei Feng and Zhou, Ping Hong},
title = {Endoscopic submucosal dissection for gastric adenocarcinoma of the fundic gland type (chief cell predominate type): Four years’ experience from a tertiary hospital},
journal = {Journal of Digestive Diseases},
year = {2022},
doi = {10.1111/1751-2980.13149}
}
EUVIMED